M Uusitupa

Author PubWeight™ 219.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001 56.11
2 Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 2001 3.73
3 Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987 2.88
4 Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 2004 2.77
5 Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia 2009 2.63
6 Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 1999 2.51
7 Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995 2.29
8 Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia 2012 1.99
9 Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia 2007 1.97
10 Synergistic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on basal metabolic rate in obese Finns. Diabetologia 1998 1.63
11 Long-term effect of betaine on risk factors associated with the metabolic syndrome in healthy subjects. Eur J Clin Nutr 2010 1.54
12 Does lactose intolerance predispose to low bone density? A population-based study of perimenopausal Finnish women. Bone 1996 1.51
13 Effect of apolipoprotein E polymorphism on serum lipid response to the separate modification of dietary fat and dietary cholesterol. Am J Clin Nutr 1998 1.47
14 Apolipoprotein E phenotype and blood pressure. Lancet 1994 1.45
15 Osteoporosis in adult patients with celiac disease. Bone 1999 1.41
16 Prevention strategies for type 2 diabetes should be based on evidence-based medical nutrition data. Diabetologia 2010 1.38
17 Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis 2001 1.37
18 High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study. Diabetologia 2006 1.32
19 Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia 2009 1.30
20 Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study. Int J Obes (Lond) 2007 1.26
21 Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg 2012 1.24
22 Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001 1.23
23 Habitual physical activity, aerobic capacity and metabolic control in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus: effect of 1-year diet and exercise intervention. Diabetologia 1992 1.16
24 Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women. J Clin Endocrinol Metab 1999 1.15
25 Caries in patients with non-insulin-dependent diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998 1.14
26 Weight change and blood coagulability and fibrinolysis in healthy obese women. Int J Obes Relat Metab Disord 2001 1.13
27 Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance. Diabet Med 2011 1.12
28 Bone recovery after a gluten-free diet: a 5-year follow-up study. Bone 1999 1.11
29 Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. J Periodontol 1998 1.10
30 HbA(1c) in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study. Diabet Med 2011 1.10
31 A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: the Sysdimet study. Diabetologia 2011 1.10
32 Rye bread decreases postprandial insulin response but does not alter glucose response in healthy Finnish subjects. Eur J Clin Nutr 1999 1.09
33 Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev 2001 1.08
34 Improved diabetic control and hypocholesterolaemic effect induced by long-term dietary supplementation with guar gum in type 2 (insulin-independent) diabetes. Diabetologia 1981 1.08
35 Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidemiol Biomarkers Prev 2001 1.07
36 Saliva in non-insulin-dependent diabetic patients and control subjects: The role of the autonomic nervous system. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998 1.04
37 Adherence to the salt restriction diet among people with mildly elevated blood pressure. Eur J Clin Nutr 1999 1.02
38 Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects. Stroke 1996 1.02
39 Association of the FTO gene variant (rs9939609) with cardiovascular disease in men with abnormal glucose metabolism--the Finnish Diabetes Prevention Study. Nutr Metab Cardiovasc Dis 2010 1.01
40 Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. Cancer Epidemiol Biomarkers Prev 2000 1.00
41 Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands. J Clin Invest 1998 1.00
42 Cardiac sympathovagal balance during sleep apnea episodes. Clin Physiol 1996 0.99
43 Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine. Diabetes 1992 0.99
44 Left ventricular function and dimensions in newly diagnosed non-insulin-dependent diabetes mellitus. Am J Cardiol 1992 0.97
45 The effects of weight loss on insulin sensitivity, skeletal muscle composition and capillary density in obese non-diabetic subjects. Int J Obes Relat Metab Disord 1996 0.96
46 Mental well-being in people with non-insulin-dependent diabetes. Acta Psychiatr Scand 1995 0.96
47 Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J Clin Endocrinol Metab 1999 0.95
48 Increased resting and exercise-induced oxidative stress in young IDDM men. Diabetes Care 1996 0.95
49 Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status. Int J Cancer 1996 0.95
50 Association of sequence variations in the gene encoding adiponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish Diabetes Prevention Study. Diabetologia 2006 0.94
51 Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: The Finnish Diabetes Prevention Study. Int J Obes (Lond) 2005 0.93
52 Diet and the risk of breast cancer in a case-control study: does the threat of disease have an influence on recall bias? J Clin Epidemiol 1999 0.93
53 Relationship of metabolic variables to abdominal adiposity measured by different anthropometric measurements and dual-energy X-ray absorptiometry in obese middle-aged women. Int J Obes Relat Metab Disord 1997 0.93
54 The effect of a very low-calorie diet-induced weight loss on the severity of obstructive sleep apnoea and autonomic nervous function in obese patients with obstructive sleep apnoea syndrome. Clin Physiol 1998 0.92
55 Prevalence of diabetes mellitus and impaired glucose tolerance in the middle-aged population of three areas in Finland. Int J Epidemiol 1991 0.92
56 Fatty acid composition of breast adipose tissue in breast cancer patients and in patients with benign breast disease. Nutr Cancer 1995 0.92
57 Blood glutathione homeostasis as a determinant of resting and exercise-induced oxidative stress in young men. Redox Rep 1999 0.91
58 Reduced serotonin transporter binding in binge eating women. Psychopharmacology (Berl) 2001 0.91
59 Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care 1990 0.91
60 Genetic risk score does not predict the outcome of obesity surgery. Obes Surg 2014 0.90
61 Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes. Physiol Genomics 2007 0.90
62 Severe hypoglycaemia caused by physical strain and pindolol therapy. A case report. Ann Clin Res 1980 0.89
63 Oral symptoms and signs in elderly patients with type 2 diabetes mellitus. A focus on diabetic neuropathy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 0.89
64 Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. Arterioscler Thromb Vasc Biol 1998 0.89
65 Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on weight change and the conversion from impaired glucose tolerance to Type 2 diabetes. The Finnish Diabetes Prevention Study. Diabetologia 2004 0.89
66 Downregulation of genes involved in NFkappaB activation in peripheral blood mononuclear cells after weight loss is associated with the improvement of insulin sensitivity in individuals with the metabolic syndrome: the GENOBIN study. Diabetologia 2008 0.88
67 Salivary matrix metalloproteinase (MMP-8) levels and gelatinase (MMP-9) activities in patients with type 2 diabetes mellitus. J Periodontal Res 2000 0.88
68 Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and Type 2 diabetes. The Finnish Diabetes Prevention Study. Diabetologia 2004 0.88
69 Short-term and long-term memory in elderly patients with NIDDM. Diabetes Care 1995 0.88
70 Intakes of nutrients and nutritional status in coeliac patients. Scand J Gastroenterol 1995 0.88
71 Polymorphism of the beta3-adrenergic receptor gene affects basal metabolic rate in obese Finns. Diabetes 1997 0.88
72 Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study. Diabetes Care 1992 0.87
73 Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects. Diabetes 1989 0.87
74 Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study. Diabetologia 2005 0.87
75 Effect of metabolic control on autonomic function in obese patients with newly diagnosed type 2 diabetes. Diabet Med 1993 0.87
76 Effect of weight loss on inflammation in patients with mild obstructive sleep apnea. Nutr Metab Cardiovasc Dis 2010 0.87
77 Impact of sugar beet pectin and polydextrose on fasting and postprandial glycemia and fasting concentrations of serum total and lipoprotein lipids in middle-aged subjects with abnormal glucose metabolism. Eur J Clin Nutr 2006 0.86
78 The effects of the Pro12Ala polymorphism of the PPARgamma-2 gene on lipid metabolism interact with body size at birth. Clin Genet 2003 0.86
79 Growth, dietary intake, and trace element status in pubescent athletes and schoolchildren. Med Sci Sports Exerc 2000 0.86
80 Toenail selenium and breast cancer-a case-control study in Finland. Eur J Clin Nutr 2000 0.86
81 Long term effects of guar gum on metabolic control, serum cholesterol and blood pressure levels in type 2 (non-insulin-dependent) diabetic patients with high blood pressure. Ann Clin Res 1984 0.86
82 Guar gum and gemfibrozil--an effective combination in the treatment of hypercholesterolaemia. Atherosclerosis 1989 0.85
83 How does lifestyle intervention affect depressive symptoms? Results from the Finnish Diabetes Prevention Study. Diabet Med 2012 0.84
84 Microfibrillar-associated protein 5 is linked with markers of obesity-related extracellular matrix remodeling and inflammation. Nutr Diabetes 2011 0.84
85 The pharmacokinetics of metformin: a comparison of the properties of a rapid-release and a sustained-release preparation. Int J Clin Pharmacol Ther Toxicol 1983 0.84
86 Nerve function and its determinants in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus and in control subjects--a 5-year follow-up. Diabetologia 1993 0.84
87 Metabolic and hormonal response to physical exercise during beta 1-selective and non-selective beta-blockade. Horm Metab Res 1982 0.84
88 Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1990 0.84
89 Aldose reductase gene polymorphisms and susceptibility to microvascular complications in Type 2 diabetes. Diabet Med 2004 0.84
90 Clustering of cardiovascular risk factors in type 2 diabetes mellitus: prognostic significance and tracking. Diabetes Obes Metab 2001 0.84
91 Effects of ageing on serotonin transporters in healthy females. Eur J Nucl Med 2001 0.83
92 Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels. Eur J Clin Nutr 1996 0.83
93 Inverse association between dietary and serum conjugated linoleic acid and risk of breast cancer in postmenopausal women. Nutr Cancer 2000 0.83
94 Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (type II) diabetic patients, with special reference to factors influencing HDL-cholesterol and triglyceride levels. Diabetes Care 1986 0.83
95 Association of the Leu72Met polymorphism of the ghrelin gene with the risk of Type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study. Diabet Med 2006 0.83
96 A controlled trial on the effects of patient education in the treatment of insulin-dependent diabetes. Diabetes Care 1983 0.83
97 The rs1800629 polymorphism in the TNF gene interacts with physical activity on the changes in C-reactive protein levels in the Finnish Diabetes Prevention Study. Exp Clin Endocrinol Diabetes 2010 0.83
98 Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women. Br J Cancer 1999 0.83
99 Long term treatment of severe hypercholesterolaemia with guar gum. Atherosclerosis 1988 0.83
100 Effect of correction of hyperglycemia on left ventricular function in non-insulin-dependent (type 2) diabetics. Acta Med Scand 1983 0.83
101 Synergistic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on long-term body weight change in Finnish type 2 diabetic and non-diabetic control subjects. Int J Obes Relat Metab Disord 2000 0.83
102 Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects. Metabolism 1988 0.83
103 Altered antioxidant enzyme defences in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stress. Acta Physiol Scand 1997 0.82
104 The importance of the electrocardiogram in ambulatory electroencephalographic recordings. Arch Neurol 1989 0.82
105 Proteinuria in newly diagnosed type II diabetic patients. Diabetes Care 1987 0.82
106 Left ventricular function in newly diagnosed non-insulin-dependent (type 2) diabetics evaluated by systolic time intervals and echocardiography. Acta Med Scand 1985 0.82
107 Blood glucose and serum insulin responses to breakfast including guar gum and cooked or uncooked milk in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1984 0.82
108 Changes in autonomic nervous function during the 4-year follow-up in middle-aged diabetic and nondiabetic subjects initially free of coronary heart disease. J Intern Med 1997 0.82
109 The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed type 2 (non-insulin-dependent) diabetes. Diabetologia 1985 0.81
110 Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. J Clin Endocrinol Metab 1997 0.81
111 Variants in the hepatocyte nuclear factor-1alpha and -4alpha genes in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes Care 2000 0.81
112 Leptin concentrations and their relation to body fat distribution and weight loss--a prospective study in individuals with impaired glucose tolerance. DPS-study group. Horm Metab Res 1999 0.81
113 Sensitivity and specificity of Minnesota Code Q-QS abnormalities in the diagnosis of myocardial infarction verified at autopsy. Am Heart J 1983 0.81
114 Insulin resistant phenotype is associated with high serum leptin levels in offspring of patients with non-insulin-dependent diabetes mellitus. Eur J Endocrinol 1998 0.81
115 Dietary intake and nutritional status of athletic and nonathletic children in early puberty. Int J Sport Nutr 1995 0.81
116 Serum concentrations and expressions of serum amyloid A and leptin in adipose tissue are interrelated: the Genobin Study. Eur J Endocrinol 2008 0.81
117 Effects of an oat bran concentrate on serum lipids in free-living men with mild to moderate hypercholesterolaemia. Eur J Clin Nutr 1992 0.80
118 Cholesterol lowering effect of metformin in combined hyperlipidemia: placebo controlled double blind trial. Ann Med 1990 0.80
119 Cardiotoxicity of epirubicin and doxorubicin: a double-blind randomized study. Eur J Haematol 1991 0.80
120 The pharmacokinetics of glibenclamide: a single dose comparison of four preparations in human volunteers. Int J Clin Pharmacol Ther Toxicol 1985 0.80
121 Effect of a three-amino acid deletion in the alpha2B-adrenergic receptor gene on long-term body weight change in Finnish non-diabetic and type 2 diabetic subjects. Int J Obes Relat Metab Disord 2001 0.80
122 Effects of bezafibrate on insulin sensitivity and glucose tolerance in subjects with combined hyperlipidemia. Clin Pharmacol Ther 1992 0.80
123 Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults. Diabetologia 2000 0.80
124 Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns. Int J Obes Relat Metab Disord 2000 0.80
125 Lifetime alcohol consumption and breast cancer: a case-control study in Finland. Public Health Nutr 2000 0.80
126 Additive effects of the mutations in the beta3-adrenergic receptor and uncoupling protein-1 genes on weight loss and weight maintenance in Finnish women. J Clin Endocrinol Metab 1998 0.80
127 Determinants of resting energy expenditure in obese non-diabetic caucasian women. Int J Obes Relat Metab Disord 1997 0.79
128 Aortic calcifications and their relationship to coronary heart disease and cardiovascular risk factors in patients with newly diagnosed non-insulin-dependent diabetes and in nondiabetic subjects. Cardiology 1987 0.79
129 Five-year follow-up of islet cell antibodies in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1991 0.79
130 Ageing and associations of fasting plasma glucose and 2 h plasma glucose with HbA(1C) in apparently healthy population. "FIN-D2D" study. Diabetes Res Clin Pract 2011 0.79
131 Common variants in beta2- and beta3-adrenergic receptor genes and uncoupling protein 1 as predictors of the risk for type 2 diabetes and body weight changes. The Finnish Diabetes Prevention Study. Clin Genet 2004 0.79
132 Family history of diabetes and effectiveness of lifestyle counselling on the cardio-metabolic risk profile in individuals at high risk of Type 2 diabetes: 1-year follow-up of the FIN-D2D project. Diabet Med 2012 0.79
133 Modification of the metabolic and hormonal response to physical exercise by beta-blocking agents. Ann Clin Res 1982 0.79
134 Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects. Diabet Med 1997 0.79
135 Association of sequence variations in the gene encoding insulin-like growth factor binding protein 5 with adiponectin. Int J Obes (Lond) 2008 0.79
136 Increased physical activity is a cornerstone in the prevention of type 2 diabetes in high-risk individuals. Diabetologia 2007 0.78
137 Decreased myocardial 123I-metaiodobenzylguanidine uptake is associated with disturbed left ventricular diastolic filling in diabetes. Am Heart J 1992 0.78
138 Vitamin E concentration in breast adipose tissue of breast cancer patients (Kuopio, Finland). Cancer Causes Control 1996 0.78
139 Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus. Diabete Metab 1987 0.78
140 Difficulties in changing the diet in relation to dietary fat intake among patients with coronary heart disease. Eur J Clin Nutr 1999 0.78
141 The genetic variation in the tenomodulin gene is associated with serum total and LDL cholesterol in a body size-dependent manner. Int J Obes (Lond) 2008 0.78
142 Testing of autonomic cardiovascular regulation--methodological considerations. Clin Physiol 1989 0.78
143 Determination of chromium in human milk, serum and urine by electrothermal atomic absorption spectrometry without preliminary ashing. Sci Total Environ 1983 0.78
144 Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 1985 0.78
145 Peripheral arterial disease and its relationship to cardiovascular risk factors and coronary heart disease in newly diagnosed non-insulin-dependent diabetics. Acta Med Scand 1986 0.78
146 Metabolic evolution of type 2 diabetes: a 10-year follow-up from the time of diagnosis. J Intern Med 1994 0.78
147 Hormonal effects of beta-receptor blockade during exercise. Acta Endocrinol (Copenh) 1983 0.77
148 Resting energy expenditure in relation to energy intake in patients with Alzheimer's disease, multi-infarct dementia and in control women. Age Ageing 1993 0.77
149 The effect of glycaemic control on the quantitative characteristics of retinopathy lesions in patients with type 2 diabetes mellitus: 10-year follow-up study. Graefes Arch Clin Exp Ophthalmol 2008 0.77
150 Nutritional status of the Finnish elite ski jumpers. Med Sci Sports Exerc 1998 0.77
151 Relationship between hyperglycaemia and aerobic power in men with newly diagnosed type 2 (non insulin-dependent) diabetes. Clin Physiol 1992 0.77
152 Effects of guar gum in male subjects with hypercholesterolemia. Am J Clin Nutr 1984 0.77
153 Relationship of blood pressure and left ventricular mass to serum insulin levels in newly diagnosed non-insulin-dependent (type 2) diabetic patients and in non-diabetic subjects. Diabetes Res 1987 0.77
154 Serum leptin and short-term regulation of eating in obese women. Clin Sci (Lond) 1997 0.77
155 Stopping insulin treatment in middle-aged diabetic patients with high postglucagon plasma C-peptide. Effect on glycaemic control, serum lipids and lipoproteins. Acta Med Scand 1988 0.77
156 A prospective study of clinical and metabolic associates of proteinuria in patients with type 2 diabetes mellitus. Diabet Med 1993 0.76
157 Cardiac arrhythmias in the differential diagnosis of epilepsy. J Neurol 1989 0.76
158 The effect of sorbinil treatment on red cell sorbitol levels and clinical and electrophysiological parameters of diabetic neuropathy. J Neurol 1986 0.76
159 Autonomic nervous function and its relationship to cardiac performance in middle-aged diabetic patients without clinically evident cardiovascular disease. J Intern Med 1992 0.76
160 Effects of two fat-modified diets on glucose and lipid metabolism in healthy subjects. Ann N Y Acad Sci 1993 0.76
161 Elevated expression of hyaluronan and its CD44 receptor in the duodenal mucosa of coeliac patients. Histopathology 2005 0.76
162 Improvement of left ventricular function after starting insulin treatment in patients with non-insulin-dependent diabetes. Diabetes Res 1988 0.75
163 Physical activity and fibrinogen concentration in newly diagnosed NIDDM. Diabetes Care 1994 0.75
164 Association of Long-Term Dietary Fat Intake, Exercise, and Weight with Later Cognitive Function in the Finnish Diabetes Prevention Study. J Nutr Health Aging 2016 0.75
165 Dietary fibre and calcium excretion in diabetes. Br Med J 1980 0.75
166 [Eggs and cholesterol--was the message of the editorial correctly interpreted?]. Duodecim 2000 0.75
167 Insulin and left ventricular hypertrophy. J Intern Med 1993 0.75
168 beta-Blockade, myopathy, and thyrotoxicosis. Br Med J 1980 0.75
169 Strawberry pickers' foot drop. Br Med J 1977 0.75
170 Metabolic and dietary determinants of serum lipids in obese patients with recently diagnosed non-insulin-dependent diabetes. Ann Med 1994 0.75
171 Chlorpropamide-alcohol flushing and coronary heart disease in non-insulin dependent diabetics. Br Med J (Clin Res Ed) 1983 0.75
172 Pharmacokinetics of graded single doses of the novel antitussive compound vadocaine hydrochloride in healthy male volunteers. Arzneimittelforschung 1988 0.75
173 [Diabetic complications in newly-diagnosed non-insulin-dependent diabetes]. Duodecim 1986 0.75
174 [The role of fish oil in the prevention and treatment of diseases]. Duodecim 1996 0.75
175 Regular eye examinations of diabetic patients in the Finnish health care system. Public Health 1994 0.75
176 The leucine (7)-to-proline (7) polymorphism in the signal peptide of neuropeptide Y is not associated with Alzheimer's disease or the link apolipoprotein E. Neurosci Lett 2000 0.75
177 Efficacy of dietary instructions in newly diagnosed non-insulin-dependent diabetic patients. Comparison of two different patient education regimens. Acta Med Scand 1987 0.75
178 Maculopathy and visual acuity in newly diagnosed type 2 diabetic patients and non-diabetic subjects: a 10-year follow-up study. Acta Ophthalmol Scand 2001 0.75
179 Assessment of the safety margin of vadocaine hydrochloride in man. Arzneimittelforschung 1988 0.75
180 [Weight loss and the functioning of the autonomic nervous system in sleep apnea patients]. Duodecim 1995 0.75
181 Left ventricular dysfunction in diabetes: evidence for the impact of metabolic factors. Diabetologia 1987 0.75
182 [Guar gum in the treatment of diabetes and hypercholesterolemia]. Duodecim 1985 0.75
183 Measurement of myocardial accumulation of 123I-metaiodobenzylguanidine for studying cardiac autonomic neuropathy in diabetes mellitus. Clin Auton Res 1996 0.75
184 [Focus on minerals - fluorine, chromium and selenium]. Duodecim 1982 0.75
185 [Thyrotoxicosis masked by beta-blockade]. Duodecim 1979 0.75
186 Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors. Thromb Haemost 1994 0.75
187 [Renal artery angioplasty in the treatment of renovascular hyper- tension]. Duodecim 1987 0.75
188 [Celiac disease, treatment guideline]. Duodecim 1997 0.75
189 [Nutritional status of hemodialysis patients]. Duodecim 1996 0.75
190 [Type 2 diabetes can be prevented by life style changes]. Duodecim 2001 0.75
191 Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer. Anticancer Res 2000 0.75
192 Endocrine and metabolic effects of guar gum in menopausal women. Gynecol Endocrinol 1993 0.75
193 [Strawberry pickers' peroneal paresis]. Duodecim 1976 0.75
194 Vitamin A concentration in breast adipose tissue of breast cancer patients. Anticancer Res 1995 0.75
195 [Gastric banding - a new operative way to treat morbid obesity]. Duodecim 1997 0.75
196 [Beta blockaders and sports]. Duodecim 1979 0.75
197 Screening for mutations in the exon 26 of the apolipoprotein B gene in hypercholesterolemic Finnish families by the single-strand conformation polymorphism method. Hum Mutat 1994 0.75
198 First human studies on the safety and antitussive activity of vadocaine hydrochloride. Arzneimittelforschung 1988 0.75
199 [Raised blood glucose level increases risk of atherosclerosis in non-insulin-dependent diabetes]. Duodecim 1994 0.75
200 Impaired ventricular repolarization associated with disturbed left ventricular sympathetic function and diastolic filling in diabetes. Am Heart J 1993 0.75
201 [Determination of C-peptide in the choice of treatment for diabetics]. Duodecim 1983 0.75
202 [Enteral vs parenteral nutrition?]. Duodecim 1994 0.75
203 A double-blind evaluation of guar gum in patients with dyslipidaemia. Hum Nutr Clin Nutr 1983 0.75
204 A double-blind comparison of two glibenclamide preparations, HB 419 and HB 420, in maturity-onset (type 2) diabetic patients. Ann Clin Res 1983 0.75
205 [Anthracycline-induced cardiotoxicity in patients with acute leukemia]. Duodecim 1983 0.75
206 [Elevated blood sedimentation rate]. Duodecim 1984 0.75
207 [Chlorpropamide and the alcohol flush reaction and coronary artery disease in adult diabetics]. Duodecim 1984 0.75
208 [Dietary fatty acids]. Duodecim 1993 0.75
209 Lack of effect of hepatic enzyme induction on metabolic control in patients with type 2 (non-insulin-dependent) diabetes. Clin Pharmacol Ther 1987 0.75
210 [Systolic time intervals and left ventricular function in coronary heart disease]. Duodecim 1982 0.75
211 Effect of diet therapy on maximum aerobic power in obese, hyperglycaemic men with recently diagnosed type 2 diabetes. Scand J Clin Lab Invest 1991 0.75
212 [The use of guar gum in treating hypercholesterolemia]. Ter Arkh 1991 0.75
213 Strawberry pickers' peroneal palsy. Electromyogr Clin Neurophysiol 1978 0.75
214 [Blood pressure disease in diabetes]. Duodecim 1989 0.75
215 Methodological variation in systolic time intervals. Clin Physiol 1984 0.75
216 Morning or bed-time insulin with or without glibenclamide in elderly type 2 diabetic patients unresponsive to oral antidiabetic agents. Diabetes Res Clin Pract 1992 0.75
217 [The effect of chromium supplementation on glucose tolerance, insulin response and serum lipids in maturity-onset diabetes]. Duodecim 1984 0.75
218 Myocardial sympathetic nervous dysfunction detected with iodine-123-MIBG is associated with low heart rate variability after myocardial infarction. J Nucl Med 1995 0.75
219 [Drug therapy of hyperglycemia and the prognosis of adult-onset diabetes mellitus]. Duodecim 1999 0.75
220 [Diabetic nephropathy--screening, follow-up and treatment. Nephropathy Study Groups of The Finnish Diabetes Organization]. Nord Med 1997 0.75
221 [Oat and celiac disease]. Duodecim 1997 0.75
222 Hyperglycaemic symptoms before diagnosis of non-insulin-dependent (type 2) diabetes mellitus in relation to 5-year outcome. J Intern Med 1992 0.75
223 [Diabetic cardiomyopathy]. Duodecim 1978 0.75
224 Early intervention in obesity: implications for impaired glucose tolerance and type II diabetes. Eur J Clin Invest 1998 0.75
225 Therapeutic traditions in type 2 diabetes--are they changing? Eur J Clin Pharmacol 1994 0.75
226 [Drug therapy in adult-onset diabetes]. Duodecim 1990 0.75
227 [What kind of fat on the bread?]. Duodecim 1995 0.75
228 [The differential diagnosis of cardiac arrhythmias and epilepsy]. Duodecim 1988 0.75
229 Validation of a short dietary questionnaire and a qualitative fat index for the assessment of fat intake. Eur J Clin Nutr 1993 0.75
230 Comparison between lovastatin and cholestyramine in the treatment of moderate to severe primary hypercholesterolaemia. Ann Med 1992 0.75
231 Non-invasive evaluation of anthracycline-induced cardiotoxicity in man. Acta Med Scand 1982 0.75
232 [Severe hypoglycemia associated with physical strain in a patient using pindolol]. Duodecim 1978 0.75